In this recording from the PSC Partners’ conference in 2018, Dr. Yinka Davies shares the promising research about vancomycin for PSC. She shares incredible case studies and discusses optimal vancomycin dosing regimens and the importance of brand and much more.

Since vancomycin is not yet FDA-approved for PSC, Dr. James Tabibian had to discuss the unknowns about vancomycin, even though he prescribes vancomycin for his PSC patients.